Clear Street’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Clear Street’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-227	Closed	-$2K	–	1503
2022 Q4	$2K	Sell	227 -46,692	-100%	-$467K	﹤0.01%	902
2022 Q3	$465K	Sell	46,919 -53,081	-53%	-$525K	0.01%	132
2022 Q2	$990K	Buy	+100,000	New	+$981K	0.04%	66

Clear Street's BIOT Position: Q1 2023 in Review

Clear Street sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 227 shares — an estimated $2K sold.

Clear Street first reported a position in BIOT in Q2 2022 and held it in 3 quarters. The position peaked at $990K in Q2 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

Clear Street reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Clear Street sold 227 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $2K.
Clear Street first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q2 2022 and held it in 3 quarters.
Clear Street's Biotech Acquisition Company Class A Ordinary Shares position peaked at $990K in Q2 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on Clear Street's 13F filing for Q1 2023, filed 12 May 2023.